In an effort to expand its reach in spotting questionable advertising and promotion of prescription drugs, the US Food and Drug Administration (FDA) is asking physicians and other health care professionals to join a kind of pharmaceutical neighborhood watch.
The Bad Ad Program, launched May 11, is the FDA's effort to better educate physicians and other health care professionals about what they can do to help the agency ensure that promotion of prescription drugs is not deceptive. It is encouraging them to report back to the agency about activities and messages they consider false or misleading, not only in print and broadcast advertising, but also during in-person activities, such as detailing.
Mitka M. Program Seeks to Enlist Physicians to Flag Questionable Promotion of Drugs. JAMA. 2010;304(1):28-29. doi:10.1001/jama.2010.861